Ethyl 1,4-dimethylpiperazine-2-carboxylate

Catalog No. :
ACHIXN165
CAS No. :
90729-01-4
Molecular Formula :
C9H18N2O2
Molecular Weight :
186.26

IUPAC Name:ethyl 1,4-dimethylpiperazine-2-carboxylate

Ethyl 1,4-dimethylpiperazine-2-carboxylate structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
1g98%$108.00Login to see priceInquiryInquiry
5g98%$291.00Login to see priceInquiryInquiry
10g98%$505.00Login to see priceInquiryInquiry
25g98%$863.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product NameEthyl 1,4-dimethylpiperazine-2-carboxylate
IUPAC Nameethyl 1,4-dimethylpiperazine-2-carboxylate
MDL No.MFCD00173923
Molecular FormulaC9H18N2O2
Molecular Weight186.26
SMILESO=C(C1N(C)CCN(C)C1)OCC
InChI KeyRRXUQLWWJFBPKT-UHFFFAOYSA-N
SynonymETHYL 1,4-DIMETHYLPIPERAZINE-2-CARBOXYLATE;BUTTPARK 47\04-32;Ethyl1,4-dimethylpiperazine-2-carboxylate97%;1,4-dimethyl-piperazine-2-carboxylic acid ethyl ester;1,4-dimethyl-2-piperazinecarboxylic acid ethyl ester;2-Piperazinecarboxylic acid, 1,4-dimethyl-, ethyl ester
CAS No.90729-01-4
PubChem CID2736419

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P280-P301+P312-P302+P352-P305+P351+P338

Synthetic Route by SureRoute

1. ACHIXN165 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACHIXN165 route product structure diagram
    ACHIXN16590729-01-4
Inquiry

2. ACHIXN165 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACHIXN165 route product structure diagram
    ACHIXN16590729-01-4
Inquiry

Comments (0)